“Racial disparity” means that a condition may happen more often in a specific racial or ethnic group than in the general population. Previous studies have shown that racial disparities exist in pregnancy and postpartum outcomes, including hypertensive disorders of pregnancy. While systemic and structural racism have been studied and shown to contribute to the disparity in outcomes for Black women, genetic ancestral contributions can also be considered. In this study, researchers asked if a gene (called HMOX1, that encodes a protein called heme oxygenase-1, or “HO-1”) may vary in patients of different ancestries. Other research studies have shown that higher levels of HO-1 are linked with inflammation and poor functioning within the blood vessels of the placenta and other organs. Patients who have higher rates of this protein appear to be at higher risk of cardiovascular disease. Studying the relationship between the HMOX1 gene and HO-1 could provide key insights into why preeclampsia may occur more often in patients of specific ancestry.
Researchers studied DNA samples from over 1,200 individuals from 5 ancestral groups: Africa, the Americas, Europe, East Asia, and South Asia (including samples provided by the Preeclampsia Registry). Results showed that HMOX1 variants (meaning - a permanent change in the DNA sequence that makes up the gene) were more common in African women. This may help to explain one reason why preeclampsia may occur more often in women of African ancestry.
Take home message: In this study, HMOX1 gene variants were different depending on ancestry, and these genetic changes could be contributing to the racial disparity in hypertensive disorders of pregnancy. More work is needed to expand this study and to test if understanding genetic variants can improve the prediction of preeclampsia and/or help to customize health care for those at risk of hypertensive disorders of pregnancy.
Link: https://link.springer.com/article/10.1007/s43032-022-01001-1
Citation: Sun, T., Cruz, G.I., Mousavi, N. et al. HMOX1 Genetic Polymorphisms Display Ancestral Diversity and May Be Linked to Hypertensive Disorders in Pregnancy. Reprod. Sci. (2022). https://doi.org/10.1007/s43032-022-01001-1
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, and MD Jenny Sones, PhD, DVM.
Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero If given in early pregnancy pravastatin, (a drug used to lower cholesterol) may decrease the risk of developing pree...
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy (a rat model) Currently the only treatment for preeclampsia starts with delivery of the baby and the placenta....
The nuMom2b study – short for “Nulliparous* Pregnancy Outcomes Study: Monitoring Mothers-To-Be” – is a prospective study that enrolled over 10,000 first time pregnant women acr...
Current Status and Prospects of the Single-Cell Sequencing Technologies for Revealing the Pathogenesis of Pregnancy-Associated Disorders The adult human body is made up of about 100 trillion cells. I...
First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics Hypertensive disorders of pregnancy and cardiovascular disease a...